Reviva Pharmaceuticals Holdings, Inc. (RVPH)
NASDAQ: RVPH · Real-Time Price · USD
1.265
+0.050 (4.13%)
Nov 21, 2024, 3:03 PM EST - Market open
RVPH Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| TTM
| FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
| Sep '24 Sep 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 |
| Selling, General & Admin | 7.8 | 8.08 | 5.36 | 5.25 | 2.14 | 0.18 | |
| Research & Development | 27.19 | 31.42 | 22.87 | 4.85 | 0.3 | 0.2 | |
| Operating Expenses | 34.99 | 39.5 | 28.23 | 10.1 | 2.43 | 0.38 | |
| Operating Income | -34.99 | -39.5 | -28.23 | -10.1 | -2.43 | -0.38 | |
| Interest Expense | - | - | - | -0 | -1.45 | -0.47 | |
| Interest & Investment Income | 0.48 | 0.5 | 0.18 | - | 0.08 | 0 | |
| Other Non Operating Income (Expenses) | 0.65 | -0.24 | -0.19 | 1.59 | 0.03 | - | |
| Pretax Income | -33.86 | -39.24 | -28.24 | -8.52 | -3.78 | -0.85 | |
| Income Tax Expense | 0.01 | 0.02 | 0.02 | 0.01 | 0 | 0 | |
| Net Income | -33.87 | -39.26 | -28.26 | -8.52 | -3.78 | -0.85 | |
| Net Income to Common | -33.87 | -39.26 | -28.26 | -8.52 | -3.78 | -0.85 | |
| Shares Outstanding (Basic) | 30 | 24 | 20 | 15 | 3 | 3 | |
| Shares Outstanding (Diluted) | 30 | 24 | 20 | 15 | 3 | 3 | |
| Shares Change (YoY) | 34.39% | 21.94% | 31.95% | 383.10% | 10.60% | - | |
| EPS (Basic) | -1.12 | -1.65 | -1.45 | -0.58 | -1.24 | -0.31 | |
| EPS (Diluted) | -1.12 | -1.65 | -1.45 | -0.58 | -1.24 | -0.31 | |
| Free Cash Flow | -33.32 | -28.32 | -18.96 | -10.67 | -4.07 | -0.22 | |
| Free Cash Flow Per Share | -1.10 | -1.19 | -0.97 | -0.72 | -1.33 | -0.08 | |
| EBITDA | - | - | - | -10.1 | -2.43 | -0.38 | |
| D&A For EBITDA | - | - | - | 0 | 0 | 0 | |
| EBIT | -34.99 | -39.5 | -28.23 | -10.1 | -2.43 | -0.38 | |
Source: S&P Capital IQ. Standard template.
Financial Sources.